HOPCo Partners with Humana to Expand MSK Population Health Program in Arizona

Healthcare Outcomes Performance Company (HOPCo) has partnered with Humana to expand its musculoskeletal (MSK) population health program to eligible Humana members in Arizona. This partnership aims to advance quality of care and optimize patient health outcomes for individuals living with MSK conditions. HOPCo's proprietary platform, which includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and a proven value-based care medical economics platform, will be deployed to Humana members in Arizona.

Key Takeaways:

• HOPCo's partnership with Humana aims to improve quality of care and optimize patient health outcomes for eligible individuals living with musculoskeletal conditions in Arizona.
• The HOPCo proprietary platform includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and a proven value-based care medical economics platform.
• HOPCo's statewide clinically integrated network (CIN), the HOPCo Specialty Care Network (HSCN), has aligned over 230 MSK specialty physicians across Arizona around clinical best practices and quality incentive metrics.
• HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, aims to align providers and members around clinical best practices.
• The platform utilizes proprietary digital engagement tools, including myrecovery®, to engage members fully upstream with primary care providers (PCPs) as well as with MSK specialists through HSCN.
• HOPCo's value-based care platform engages members and providers across the entire MSK care continuum at all points of care.
• The partnership with Humana is designed to advance quality of care and help optimize patient health outcomes for eligible individuals living with musculoskeletal conditions.

Statistics:

• HOPCo's HSCN has aligned over 230 MSK specialty physicians across Arizona around clinical best practices, quality incentive metrics, and real-time claims analytics.
• The HSCN is the only URAC-accredited MSK CIN in the country.
• HOPCo's proprietary platform includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and a proven value-based care medical economics platform.

Sources:

• Healthcare Outcomes Performance Company
• Humana Inc. (NYSE: HUM)
• PHOENIX, Oct. 28